Events and Webcasts


09:00 September 05, 2017 ‐ 19:07 08 September, 2017

The 3rd Annual CAR-TCR Summit will be held from Tuesday, September the 5th to Friday, September the 8th, 2017, in Boston, USA.

André Choulika, Chairman and Chief Executive Officer of Cellectis, to take part in this event on Wednesday, September the 6th from 8.45 to 10.15 AM during the "Industry Leaders’ Fireside Chat" panel.

David Sourdive, Executive Vice President Technical Operations, to take part in this event on Friday, September the 8th from 9:00 to 11:00 AM with a presentation entitled "Autologous vs Allogeneic: How Can We Make Allogeneic Therapies a Reality" during the session K.

Julianne Smith, Ph.D., VP Translational Sciences, to take part in this conference on wednesday the 6th from 5:05 to 5:35 PM with a presentation entitled "Gene Edited Allogeneic CAR T-Cell Therapy" in the CAR-TCR Translation Stream.